Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Untargeted metabolomics of COVID-19 patient serum reveals potential prognostic markers of both severity and outcome

View ORCID ProfileIvayla Roberts, View ORCID ProfileMarina Wright Muelas, Joseph M. Taylor, View ORCID ProfileAndrew S. Davison, Yun Xu, View ORCID ProfileJustine M. Grixti, Nigel Gotts, Anatolii Sorokin, Royston Goodacre, View ORCID ProfileDouglas B. Kell
doi: https://doi.org/10.1101/2020.12.09.20246389
Ivayla Roberts
1Department of Biochemistry and Systems Biology, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Ivayla Roberts
Marina Wright Muelas
1Department of Biochemistry and Systems Biology, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Marina Wright Muelas
  • For correspondence: m.wright-muelas@liverpool.ac.uk douglas.kell@liverpool.ac.uk
Joseph M. Taylor
2Department of Clinical Biochemistry and Metabolic Medicine, Liverpool Clinical Laboratories, Royal Liverpool University Hospitals Trust, Liverpool, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrew S. Davison
2Department of Clinical Biochemistry and Metabolic Medicine, Liverpool Clinical Laboratories, Royal Liverpool University Hospitals Trust, Liverpool, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Andrew S. Davison
Yun Xu
1Department of Biochemistry and Systems Biology, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Justine M. Grixti
1Department of Biochemistry and Systems Biology, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Justine M. Grixti
Nigel Gotts
1Department of Biochemistry and Systems Biology, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anatolii Sorokin
1Department of Biochemistry and Systems Biology, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Royston Goodacre
1Department of Biochemistry and Systems Biology, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Douglas B. Kell
1Department of Biochemistry and Systems Biology, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, UK
3Novo Nordisk Foundation Centre for Biosustainability, Technical University of Denmark, Building 220, Chemitorvet, Kgs Lyngby 2000, Denmark
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Douglas B. Kell
  • For correspondence: m.wright-muelas@liverpool.ac.uk douglas.kell@liverpool.ac.uk
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

The diagnosis of COVID-19 is normally based on the qualitative detection of viral nucleic acid sequences. Properties of the host response are not measured but are key in determining outcome. Although metabolic profiles are well suited to capture host state, existing metabolomics studies are either underpowered, measure only a restricted subset of metabolites (‘targeted metabolomics’), compare infected individuals against uninfected control cohorts that are not suitably matched, or do not provide a compact predictive model.

We here provide a well-powered, untargeted metabolomics assessment of 120 COVID-19 patient samples acquired at hospital admission. The study aims to predict patient’s infection severity (i.e. mild or severe) and potential outcome (i.e. discharged or deceased).

High resolution untargeted LC-MS/MS analysis was performed on patient serum using both positive and negative ionization. A subset of 20 intermediary metabolites predictive of severity or outcome were selected based on univariate statistical significance and a multiple predictor Bayesian logistic regression model. The predictors were selected for their relevant biological function and include cytosine (reflecting viral load), kynurenine (reflecting host inflammatory response), nicotinuric acid, and multiple short chain acylcarnitines (energy metabolism) among others.

Currently, this approach predicts outcome and severity with a Monte Carlo cross validated area under the ROC curve of 0.792 (SD 0.09) and 0.793 (SD 0.08), respectively. Prognostic tests based on the markers discussed in this paper could allow improvement in the planning of COVID-19 patient treatment.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

We thank the UK BBSRC (grant BB/V003976/1) and the Novo Nordisk Foundation (grant NNF10CC1016517) for financial support.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Ethical approval was obtained to use the samples included in the study from the Health Regulatory Authority and Health and Care Research Wales (HCRW), and the North-West England Research Ethics (ref: 20/NW/0332).

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Data will be uploaded to Metabolights

https://www.ebi.ac.uk/metabolights/

  • Abbreviations

    AEX-LC-MS/MS
    anion-exchange LC-MS
    AF
    atrial fibrillation
    ALT
    alanine aminotransferase
    ARDS
    acute respiratory distress syndrome
    AUC
    area under the curve
    BMI
    body mass index
    BP
    systolic blood pressure
    CI
    confidence interval
    COVID-19
    Coronavirus disease 2019
    CPAP
    continuous positive airway pressure
    CRP
    C-reactive protein
    CRS
    cytokine release storms
    CV
    coefficient of variation
    eGFR
    estimated glomerular filtration rate
    ESI
    electrospray ionization
    FC
    fold change
    FDR
    false discovery rate
    FIO2
    fraction of inspired oxygen
    GC-MS
    gas chromatography mass spectrometry
    GCS
    Glasgow coma scale
    GLM
    generalized linear models
    Hb
    haemoglobin levels
    HCT
    hematocrit
    IHD
    ischaemic heart disease
    IQA
    inter-batch quality assurance
    LC-MS
    liquid chromatography mass spectrometry
    LC-MS/MS
    liquid chromatography tandem mass spectrometry
    LFC
    log fold change
    Lymphs
    lymphocyte count
    MB-PCA
    multiblock PCA
    MSI
    metabolomics Standards Initiative
    MSML
    mass spectrometry metabolite library
    NEWS
    national early warning score
    NICE
    national institute for health and care excellence
    NMR
    nuclear magnetic resonance
    OR
    odds ratio
    PCA
    principal component analysis
    PCR
    polymerase chain reaction
    PLTs
    platelets count
    QC
    quality control
    RLUH
    royal Liverpool university hospital
    ROC
    receiver operating characteristic
    rRNA
    ribosomal RNA
    RT
    retention time
    RTPCR
    reverse transcription PCR
    SARS-CoV-2
    severe acute respiratory syndrome coronavirus-2
    SD
    standard deviation
    SOB
    shortness of breath
    WBC
    white blood cell count
  • Copyright 
    The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
    Back to top
    PreviousNext
    Posted December 11, 2020.
    Download PDF

    Supplementary Material

    Data/Code
    Email

    Thank you for your interest in spreading the word about medRxiv.

    NOTE: Your email address is requested solely to identify you as the sender of this article.

    Enter multiple addresses on separate lines or separate them with commas.
    Untargeted metabolomics of COVID-19 patient serum reveals potential prognostic markers of both severity and outcome
    (Your Name) has forwarded a page to you from medRxiv
    (Your Name) thought you would like to see this page from the medRxiv website.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Share
    Untargeted metabolomics of COVID-19 patient serum reveals potential prognostic markers of both severity and outcome
    Ivayla Roberts, Marina Wright Muelas, Joseph M. Taylor, Andrew S. Davison, Yun Xu, Justine M. Grixti, Nigel Gotts, Anatolii Sorokin, Royston Goodacre, Douglas B. Kell
    medRxiv 2020.12.09.20246389; doi: https://doi.org/10.1101/2020.12.09.20246389
    Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
    Citation Tools
    Untargeted metabolomics of COVID-19 patient serum reveals potential prognostic markers of both severity and outcome
    Ivayla Roberts, Marina Wright Muelas, Joseph M. Taylor, Andrew S. Davison, Yun Xu, Justine M. Grixti, Nigel Gotts, Anatolii Sorokin, Royston Goodacre, Douglas B. Kell
    medRxiv 2020.12.09.20246389; doi: https://doi.org/10.1101/2020.12.09.20246389

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Subject Area

    • Infectious Diseases (except HIV/AIDS)
    Subject Areas
    All Articles
    • Addiction Medicine (160)
    • Allergy and Immunology (413)
    • Anesthesia (90)
    • Cardiovascular Medicine (855)
    • Dentistry and Oral Medicine (159)
    • Dermatology (97)
    • Emergency Medicine (248)
    • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (393)
    • Epidemiology (8550)
    • Forensic Medicine (4)
    • Gastroenterology (383)
    • Genetic and Genomic Medicine (1744)
    • Geriatric Medicine (167)
    • Health Economics (371)
    • Health Informatics (1237)
    • Health Policy (619)
    • Health Systems and Quality Improvement (467)
    • Hematology (196)
    • HIV/AIDS (372)
    • Infectious Diseases (except HIV/AIDS) (10281)
    • Intensive Care and Critical Care Medicine (552)
    • Medical Education (192)
    • Medical Ethics (51)
    • Nephrology (210)
    • Neurology (1670)
    • Nursing (97)
    • Nutrition (248)
    • Obstetrics and Gynecology (325)
    • Occupational and Environmental Health (450)
    • Oncology (926)
    • Ophthalmology (263)
    • Orthopedics (100)
    • Otolaryngology (172)
    • Pain Medicine (112)
    • Palliative Medicine (40)
    • Pathology (252)
    • Pediatrics (534)
    • Pharmacology and Therapeutics (247)
    • Primary Care Research (207)
    • Psychiatry and Clinical Psychology (1764)
    • Public and Global Health (3832)
    • Radiology and Imaging (622)
    • Rehabilitation Medicine and Physical Therapy (319)
    • Respiratory Medicine (520)
    • Rheumatology (207)
    • Sexual and Reproductive Health (165)
    • Sports Medicine (157)
    • Surgery (190)
    • Toxicology (36)
    • Transplantation (101)
    • Urology (74)